| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8739634 | Journal of Clinical Virology | 2018 | 6 Pages |
Abstract
Young children and immunocompromised patients are likely the risk groups for severe respiratory infections with hPIV-3. Strains belonging to lineages C3c and C1b, which are present worldwide, should be targeted in vaccine development. The emergence of new lineage might have public health implications and on vaccine development.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Irina Jornist, Khitam Muhsen, Daniela Ram, Yaniv Lustig, Virginia Levy, Sara Orzitser, Roberto Azar, Merav Weil, Viki Indenbaum, Danit Sofer, Ella Mendelson, Michal Mandelboim, Musa Hindiyeh,